Dermatologic Oncology — Dermatology

Dermatology · Clinical Specialties

How it begins

Estudio exhaustivo de las neoplasias cutáneas malignas — biología molecular, diagnóstico clínico-dermatoscópico, estadificación y terapéutica de precisión en la era de la inmunooncología.

What it covers

1. Introduction and Epidemiology
2. · 1.1 Global Epidemiology
3. · 1.2 Risk Factors
4. Cutaneous Melanoma
5. · 2.1 Clinical-Pathological Classification
6. · 2.2 Molecular Pathogenesis of Melanoma
7. · 2.3 Clinical and Dermatoscopic Diagnosis
8. · 2.4 Histological Diagnosis and Anatomopathological Prognostic Factors
9. · 2.5 Staging — AJCC System 9th Edition (2022)
10. · 2.6 Selective Sentinel Node Biopsy (SLNB)
11. · 2.7 Treatment of Melanoma Stages I–III
12. · 2.8 Treatment of Metastatic Melanoma (Stage IV)
13. Basal Cell Carcinoma (BCC)
14. · 3.1 Clinical-Histological Subtypes and Risk
15. · 3.2 Treatment of BCC
16. Cutaneous Squamous Cell Carcinoma (SCC)
17. · 4.1 Precursor Lesions and the Spectrum of Squamous Carcinogenesis
18. · 4.2 Treatment of CEC
19. High Risk and Rare Skin Tumors
20. · 5.1 Merkel Cell Carcinoma (MCC)
21. · 5.2 Dermatofibrosarcoma Protuberans (DFSP)
22. · 5.3 Cutaneous Angiosarcoma
23. Kaposi's sarcoma (KS)
24. Primary Cutaneous Lymphomas
25. · 7.1 Mycosis Fungoid (MF)
26. · 7.2 Sézary syndrome (SS)
27. · 7.3 Cutaneous B-Cell Lymphomas and Others LCPCT
28. Cutaneous Metastases
29. Immuno-oncology in Dermatology: Skin Toxicities
30. Prevention, Early Detection and Future Perspectives
31. · 10.1 Photoprotection — Evidence and Recommendations
32. · 10.2 Follow-up and Early Detection of Melanoma